Description

Prolatan (latanoprost) Eye Drops 0.005% 2.5 ml Vial №1

Ingredients

Active ingredient: Latanoprost 0.005%. Other ingredients may include benzalkonium chloride, sodium chloride, sodium dihydrogen phosphate monohydrate, and water for injection.

Dosage

Dosage: The usual recommended dose is one drop in the affected eye(s) once daily in the evening.

Indications

Indications: Prolatan eye drops are indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Contraindications

Contraindications: Do not use Prolatan eye drops if you are allergic to any of the ingredients. Consult your healthcare provider before use if you are pregnant, nursing, or have a history of eye surgery.

Directions

Directions: Wash hands before use. Tilt your head back, pull down the lower eyelid, and instill the prescribed number of drops. Close the eye for 1 to 2 minutes without blinking.

Scientific Evidence

Prolatan (latanoprost) has been extensively studied for its efficacy in reducing intraocular pressure. Clinical trials have shown that latanoprost is effective in lowering IOP by increasing the outflow of aqueous humor from the eye, making it a first-line treatment for glaucoma.

Additional Information

It is important to use Prolatan eye drops as prescribed by your healthcare provider to achieve the best results. Contact your doctor if you experience any side effects such as eye irritation, redness, or blurred vision.

Pharmacological Effects

Latanoprost, the active ingredient in Prolatan eye drops, is a prostaglandin analog that works by increasing the outflow of aqueous humor from the eye. By enhancing the uveoscleral outflow, latanoprost helps to reduce intraocular pressure, thereby protecting the optic nerve from damage associated with conditions like glaucoma.

Clinical Trials and Comparative Effectiveness

Numerous clinical trials have demonstrated the efficacy and safety of latanoprost in the management of glaucoma and ocular hypertension. In comparative studies, latanoprost has shown similar or better efficacy compared to other classes of glaucoma medications, making it a preferred choice for many healthcare providers.

• Study 1: A randomized controlled trial comparing latanoprost with timolol in patients with open-angle glaucoma showed a significant reduction in intraocular pressure with latanoprost.
• Study 2: A meta-analysis of clinical trials concluded that latanoprost is well-tolerated and effective in lowering intraocular pressure.